IP Library Patent Application 12266116
Patent Application
App. No. 12/266,116

ISOLATION AND TRANSPLANTATION OF RETINAL STEM CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/266,116
Abstract

The present invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, ex vivo and in vivo.

Claims (21)

1 . Retinal stem cells isolated from a neuroretina of a donor mammal.

2 . Retinal stem cells isolated from a neuroretina of a donor mammal, being capable of:

a) self-renewal in vitro;

b) differentiating into any one cell type of the group consisting of neurons, astrocytes, and oligodendrocytes;

c) integration into a host retina when grafted on the host retina; and

d) differentiation into photoreceptor cells when grafted onto a retina, onto a retinal explants, or into a mature eye.

3 . The retinal stem cells of claim 1 or 2 , wherein the retinal stem cells express nestin and are non-pigmented.

4 . The retinal stem cells of claim 1 or 2 , said cells requiring, when cultured in vitro, the presence at least one exogenous growth factor in a culture medium in order to proliferate.

5 . The retinal stem cells of claim 4 , wherein at least one exogenous growth factor is a member selected from the group consisting of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), a combination of bFGF and EGF, and a combination of EGF and bFGF and platelet-derived growth factor (PDGF).

6 . The retinal stem cells of claim 1 or 2 , which can differentiate into neurons, as evidenced by expression of a neurofilament protein, NF-200.

7 . The retinal stem cells of claim 1 or 2 , which can differentiate into astrocytes, as evidenced by expression of glial fibrillary acidic protein, GFAP.

8 . The retinal stem cells of claim 1 or 2 , which, when grafted onto a retina, onto a retinal explants, or into a mature eye, differentiate into photoreceptor cells expressing rhodopsin, recoverin, or both.

9 . The retinal stem cells of claim 8 , further being capable of integrating into and repopulating a diseased retina.

10 . The retinal stem cells of claim 1 or 2 , wherein the mammal is an embryo, a neonate, or an adult.

11 . The retinal stem cells of claim 1 or 2 , wherein the mammal is a primate, a rodent, or a domesticated animal.

12 . The retinal stem cells of claim 1 or 2 , wherein the mammal is a human, a mouse, a rat, a cat, a dog, a pig, a cow, a horse, a monkey, or a great ape.

13 - 24 . (canceled)

25 . The neuroretina-derived retinal stem cells of claim 1 or 2 , wherein the mammal was is a transgenic mouse expressing green fluorescent protein.

26 . The neuroretina-derived retinal stem cells of claim 1 or 2 , being clonally derived.

27 - 45 . (canceled)

46 . The retinal stem cells of claim 1 which are derived from a neurosphere.

Assignments (1)
LICENSE Recorded Sep 17, 2018
From: THE SCHEPENS EYE RESEARCH INSTITUTE
To: RENEURON LIMITED
Reel/Frame 047099/0078 →